Saavedra, Jacqueline .
HRN: 19-96-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/30/2024
01/06/2025
PO
2.5 Ml
Q8h
UTI, PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes